Correlation of drug absorption with molecular surface properties.
暂无分享,去创建一个
K. Luthman | P. Artursson | A. Ungell | K. Palm | G. Strandlund | Kristina Luthman | Gert Strandlund | Katrin Palm
[1] B. Lee,et al. The interpretation of protein structures: estimation of static accessibility. , 1971, Journal of molecular biology.
[2] Samuel H. Yalkowsky,et al. Solubility of nonelectrolytes in polar solvents. V. Estimation of the solubility of aliphatic monofunctional compounds in water using a molecular surface area approach , 1975 .
[3] C Silipo,et al. Calculation of hydrophobic constant (log P) from pi and f constants. , 1975, Journal of medicinal chemistry.
[4] W. Higuchi,et al. Quantitative mechanistic studies in simultaneous fluid flow and intestinal absorption using steroids as model solutes , 1980 .
[5] Y. Martin,et al. A practitioner's perspective of the role of quantitative structure-activity analysis in medicinal chemistry. , 1981, Journal of medicinal chemistry.
[6] R. Pownall,et al. The absorption of β‐adrenoceptor antagonists in rat in‐situ small intestine; the effect of lipophilicity , 1985, The Journal of pharmacy and pharmacology.
[7] H. Scheraga,et al. Accessible surface areas as a measure of the thermodynamic parameters of hydration of peptides. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[8] W J Dunn,et al. The role of solvent-accessible surface area in determining partition coefficients. , 1987, Journal of medicinal chemistry.
[9] 6th International Symposium of Nephrology at Montecatini on Kidney, Proteins and Drugs , 1988 .
[10] R Griffiths,et al. Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists. , 1988, Journal of medicinal chemistry.
[11] Kenny B. Lipkowitz,et al. Dynamic molecular surface areas , 1989 .
[12] G. Chang,et al. Macromodel—an integrated software system for modeling organic and bioorganic molecules using molecular mechanics , 1990 .
[13] Raimund Mannhold,et al. Drug lipophilicity in QSAR practice. I: A comparison of experimental with calculative approaches , 1990 .
[14] P. Artursson,et al. Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. , 1990, Journal of pharmaceutical sciences.
[15] P. Artursson. Cell cultures as models for drug absorption across the intestinal mucosa. , 1991, Critical reviews in therapeutic drug carrier systems.
[16] P. Artursson,et al. A method for the determination of cellular permeability coefficients and aqueous boundary layer thickness in monolayers of intestinal epithelial caco 2 cells grown in permeable filter chambers , 1991 .
[17] R. Frizzell,et al. Intestinal absorption and secretion , 1991 .
[18] P. Artursson,et al. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.
[19] G. Painter,et al. Role of desolvation energy in the nonfacilitated membrane permeability of dideoxyribose analogs of thymidine. , 1992, Molecular pharmacology.
[20] A. Ungell,et al. Effects of enzymatic inhibition and increased paracellular shunting on transport of vasopressin analogues in the rat. , 1992, Journal of pharmaceutical sciences.
[21] M. Kansy,et al. Hydrogen-Bonding Capacity and Brain Penetration , 1992, Chimia (Basel).
[22] M C Manning,et al. Delta-sleep-inducing peptide: solution conformational studies of a membrane-permeable peptide. , 1994, Biochemistry.
[23] Bernard Testa,et al. Lipophilicity and hydrogen-bonding capacity of H1-antihistaminic agents in relation to their central sedative side-effects , 1994 .
[24] D. Barlow,et al. The design of peptide analogues for improved absorption , 1994 .